Clinical study to evaluate the effectiveness of gandhaga sudar thailam (internal) for the management of bacterial vaginosis in women.

An open-label pilot clinical trial to evaluate the effectiveness of gandhaga sudar thailam (internal) for the management of vellai noi (bacterial vaginosis) in women. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092398

Enrollment

Registered

2025-08-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N760- Acute vaginitis

Interventions

Intervention1: Gandhaga Sudar Thailam: 10 drops, twice a day, after food for 10 days Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: Married women in the age group of 18-45 years. Women willing to provide a vaginal swab. (Swab will be collected under the guidance of a gynaecologist.) Amsel criteria for bacterial vaginosis.

Exclusion criteria

Exclusion criteria: Pregnancy & lactation Known cases of sexually transmitted diseases (Syphilis, HIV, Gonorrhoea) Known medical history of uterine prolapse. Known case of Malignancy in uterus & ovary. Women who have attained menopause. Women who received antibiotics within the past 2 days of enrolment or who took spermicides. Menstruating females. Immunocompromised patients.

Design outcomes

Primary

Measure	Time frame
The effectiveness of the trial drug is assessed by reduction in severity of symptoms and through vaginal swab.Timepoint: 10 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026